193
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Examination of neurological prognostic markers in patients with respiratory syncytial virus-associated encephalopathy

, , , , , & show all
Pages 44-50 | Received 17 May 2015, Accepted 04 Jan 2016, Published online: 01 Feb 2016

References

  • Aujard Y, Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Resp Med 2002;96(suppl):S9–14.
  • Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks gestation. Pediatrics 1991;88:527–32.
  • Ng YT, Cox C, Atkins J, et al. Encephalopathy associated with respiratory syncytial virus bronchiolitis. J Child Neurol 2001;16:105–8.
  • Sweetman LL, Ng YT, Butler IJ, et al. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol 2005;32:307–10.
  • Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J 2004;23:1065–6.
  • Otake Y, Yamagata T, Morimoto Y, et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev 2007;29:117–20.
  • Hoshino A, Saitoh M, Oka A, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 2012;34:337–43.
  • Park A, Suh SI, Son GR, et al. Respiratory syncytial virus-related encephalitis: magnetic resonance imaging findings with diffusion-weighted study. Neuroradiology 2014;56:163–8.
  • Tison-Chambellan C, Cheuret E, Cances C, et al. Respiratory syncytial virus brainstem encephalitis in a 7-year-old boy. Arch Pediatr 2013;20:657–60.
  • Cheng FB, Li YH, Jin GH, et al. Respiratory syncytial virus encephalitis with symmetrical bilateral hemispheric lesions in an adult. Neurol India 2010;58:489–90.
  • De Boeck K, Van der Aa N, Van Lierde S, et al. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr 1997;131(6):919–21.
  • Mizuguchi M, Yamanouchi H, Ichiyama T, et al. Acute encephalopathy associated with influenxa and other viral infections. Acta Neurol Scand 2007;115:45–56.
  • Kawano G, Iwata O, Iwata S, et al. Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling. Arch Dis Child 2011;96:936–41.
  • Kawashima H, H Ioi, Y Hasegawa, et al. Life-threatening extrapulmonary manifestations associated with respiratory syncytial virus infection in Japan. J Tokyo Med Univ 2008;66:549–52.
  • Li SJ, Liu W, Wang JL, et al. The role of TNF-α, IL-6, IL-10, and GDNF in neuronal apoptosis in neonatal rat with hypoxic-ischemic encephalopathy. Eur Rev Med Pharmacol Sci. 2014;18:905–9.
  • Ichiyama T, Suenaga N, Kajimoto M, et al. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev 2008;30:47–52.
  • Ichiyama T, Morishima T, Isumi H, et al. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 2004;27:31–7.
  • Tsukahara H, Fujii Y, Matsubara K, et al. Prognostic value of brain injury biomarkers in acute encephalitis/encephalopathy. Pediatr Int 2013;55:461–4.
  • Shiihara T, Miyake T, Izumi S, et al. Serum and CSF biomarkers in acute pediatric neurological disorders. Brain Dev 2014;36:489–95.
  • Morichi S, Kawashima H, Ioi H, et al. Classification of acute encephalopathy in respiratory syncytial virus infection. J Infect Chemother 2011;17(6):776–81.
  • Chiaretti A, Antonelli A, Mastrangelo A, et al. Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma 2008;25:225–34.
  • Hosoya M, Kawasaki Y, Katayose M, et al. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child 2006;91:469–72.
  • Kawashima H, Kashiwagi Y, Ioi H, et al. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infect Chemother 2012;18(6):827–31.
  • Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549–53.
  • Tokunaga Y, Kira R, Takahata Y, et al. Neurotrophin-4 and glial cell line-derived neurotrophic factor in cerebral fluid from meningitis/encephalitis patients. Pediatr Neurol 2002;27:102–5.
  • Chiaretti A, Antonelli A, Piastra M, et al. Expression of neurotrophic factors in CSF and plasma of children with viral and bacterial meningoencephalitis. Acta Paediatr 2004;93:1178–84.
  • Mizuno Y, Takada H, Urakami K, et al. Neurotrophin-3 levels in CSF from children with bacterial meningitis, viral meningitis, or encephalitis. J Child Neurol 2000;15:19–21.
  • Morichi S, Kashiwagi Y, Takekuma K, et al. Expressions of brain-derived neurotrophic factor (BDNF) in CSF and plasma of children with meningitis and encephalitis/encephalopathy. Int J Neurosci 2013;123:17–23.
  • Nieto-Sampiedro M, Lewis ER, Cotman CW, et al. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science 1982;217:860–1.
  • Takeda K, Shiba H, Mizuno N, et al. Brain-derived neurotrophic factor enhances periodontal tissue regeneration. Tissue Eng 2005;11:1618–29.
  • Matsuda S, Fujita T, Kajiya M, et al. Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin αVβ3-FAK cascade. J Cell Physiol 2012;227:2123–9.
  • Moalem G, Gdalyahu A, Shani Y. Production of neurotrophins by activated Tcells: implications for neuroprotective autoimmunity. J Autoimmun 2000;15:331–45.
  • Yoshimura R, Umene-Nakano W, Hoshuyama T, et al. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls. Hum Psychopharmacol 2010;25:566–9.
  • Shiihara T, Kato M, Ichiyama T, et al. Acute encephalopathy with refractory status epilepticus: bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage. J Neurol Sci 2006;250:159–61.
  • Duarte S, Sanmarti F, Gonzalez V, et al. Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies. Brain Dev 2008;30:106–11.
  • Espinoza JA, Bohmwald K, Céspedes PF, et al. Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci USA 2013;110:9112–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.